Zota Health Care LImited
Zota Health Care LImited (ZOTA): company summary
The company's revenue grew by 84.5% annually, but net profit turned into a loss, widening from a ₹57 crore loss to a ₹74 crore loss.
Zota Health Care LImited (ZOTA) is a micro-cap Healthcare company valued at ₹4,881 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Zota Health Care LImited last traded at ₹1,412.7, up 3.24% on the day.
- Recent developments
- On 2026-09-21, the company announced a dividend of ₹1.00 per share, with the ex-date set for that date. Promoter holding remained at 49.38% as of 2026-06-30, with 0.26% of promoter shares pledged. Domestic institutional holding decreased by 0.29 percentage points to 6.75%.
- Financial performance
- The company's revenue grew by 84.5% annually, but net profit turned into a loss, widening from a ₹57 crore loss to a ₹74 crore loss. The latest quarter saw revenue rise 66.9% year-on-year, but the net loss widened from ₹14 crore to ₹44 crore, with the net profit margin improving slightly to -13.8% from -19.5%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 5.49 times book value.
- Things to watch
- The company reported a net loss of ₹74 crore in its latest financial year, with the loss widening from ₹57 crore the previous year. The latest quarter's net loss widened from ₹14 crore to ₹44 crore, and return on equity and return on capital employed remain negative at -10.7% and -8.7% respectively.
- Where it stands
- The company's revenue has grown rapidly, but net profit remains in loss, with the latest quarter's loss widening significantly. The stock is 27.1% below its 52-week high, and the net profit margin improved slightly despite the loss. The company's debt-to-equity ratio is almost debt-free at 0.04.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and risk (6.0), but held back by valuation (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 0.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 38% a year
- Low leverage — D/E 0.04
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Zota Health Care LImited’s valuation
Free deep-dive tools · no sign-up
Zota Health Care LImited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Zota Health Care LImited with peers
Related tools & concepts
Value Zota Health Care LImited with the ratios and calculators DocStoX uses in its analysis.

